Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  International Immunology

• Publication date

  1998-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/INTIMM/10.2.195PMID 9533447
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils.

  1997cited by this paper
• Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.

  1997cited by this paper
• Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.

  1997cited by this paper
• Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.

  1997cited by this paper
• A license to kill.

  1996cited by this paper
• Enhanced and accelerated lymphoproliferation in Fas-null mice.

  1996cited by this paper
• Clinical, immunological, and pathological consequences of Fas-deficient conditions.

  1996influential reference
• Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway.

  1996cited by this paper
• Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.

  1996cited by this paper
• Fas ligand in human serum

  1996cited by this paper
• Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing.

  1995cited by this paper
• Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

  1995cited by this paper
• Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation

  1995cited by this paper
• Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor

  1995cited by this paper
• Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

  1995cited by this paper
• Fas ligand mediates activation-induced cell death in human T lymphocytes

  1995cited by this paper
• The Fas death factor

  1995cited by this paper
• CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway

  1995cited by this paper
• Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bax, Bcl-X and Mcl-1, in human peripheral blood and lymphoid tissues.

  1995cited by this paper
• Fas and Fas ligand: lpr and gld mutations.

  1995cited by this paper
• Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias.

  1995cited by this paper
• Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver

  1995cited by this paper
• FAP-1: a protein tyrosine phosphatase that associates with Fas.

  1995cited by this paper
• Fas and FasL in the homeostatic regulation of immune responses.

  1995cited by this paper
• Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.

  1995cited by this paper
• Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells.

  1994cited by this paper
• Structure of the human APO‐1 gene

  1994cited by this paper
• Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

  1994cited by this paper
• Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils.

  1994cited by this paper
• Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.

  1994cited by this paper
• Fas transduces activation signals in normal human T lymphocytes

  1993influential reference
• APO‐1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: Correlation with bcl‐2 oncogene expression

  1993cited by this paper
• Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.

  1993cited by this paper
• Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice.

  1993cited by this paper
• Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood.

  1992cited by this paper
• The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen.

  1992cited by this paper
• Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen.

  1992cited by this paper
• The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

  1991cited by this paper
• Monoclonal antibody-mediated tumor regression by induction of apoptosis.

  1989cited by this paper
• A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

  1989cited by this paper

• Incomplete penetrance in inborn errors of immunity: A skeleton in the closet—The sequel

  2025cites this paper
• Novel Compound Heterozygous Variants in the FAS Gene Lead to Fetal Onset of Autoimmune Lymphoproliferative Syndrome (ALPS)

  2024cites this paper
• Case report: Neonatal autoimmune lymphoproliferative syndrome with a novel pathogenic homozygous FAS variant effectively treated with sirolimus

  2023cites this paper
• Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations.

  2023cites this paper
• Nem malignus, nem infectiosus lymphoproliferatio: kihívások az autoimmun lymphoproliferativ szindróma diagnosztikájában és kezelésében

  2022cites this paper
• The contribution of rare copy number variants in FAS toward pathogenesis of autoimmune lymphoproliferative syndrome

  2022cites this paper
• Non-malignant, non-infectious lymphoproliferation: challenges in the diagnosis and treatment of autoimmune lymphoproliferative syndrome

  2022cites this paper
• Inborn Errors of Immunity With Fetal or Perinatal Clinical Manifestations

  2022cites this paper
• ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies

  2022cites this paper
• Genetik in der pädiatrischen Rheumatologie

  2021cites this paper
• Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS‐like diseases: A systematic review

  2021cites this paper
• Impact of human CD95 mutations on cell death and autoimmunity: a model.

  2021cites this paper
• Incomplete penetrance in primary immunodeficiency: a skeleton in the closet

  2020cites this paper
• Neonatal Autoimmune Lymphoproliferative Syndrome (ALPS): A Case Report and A Brief Review.

  2020cites this paper
• [Autoimmune lymphoproliferative syndrome. Update and review].

  2019cites this paper
• The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions

  2018cites this paper
• An updated view on the functions of caspases in inflammation and immunity.

  2018cites this paper
• FAS and RAS related Apoptosis defects: From autoimmunity to leukemia

  2018cites this paper
• The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions

  2018cites this paper
• Rare splicing defects of FAS underly severe recessive autoimmune lymphoproliferative syndrome.

  2017cites this paper
• Novel insights into FAS defects underlying autoimmune lymphoproliferative syndrome revealed by studies in consanguineous patients

  2017cites this paper
• Cytokine Profiling in a Familial Case of Autoimmune Lymphoproliferative Syndrome with Co-mutations of FAS and MEFV

  2017cites this paper
• Apoptosis-Related Autoimmune Lymphoproliferative Syndrome

  2016cites this paper
• Fas-Deficient Target Cells Perforin-Deficient Effector Cells and Using the Combination of Hereditary T Lymphocytes: Analysis + Human CD4 Antigen-Specific Cytotoxicity Mediated by Essential Roles of Perforin in

  2013cites this paper
• Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation.

  2013cites this paper
• Activation-induced cell-death of human T-lymphocytes Perforin-dependent apoptosis functionally compensates Fas-deficiency in

  2013cites this paper
• CD8+ cytotoxic T lymphocytes in humans pathway of cytotoxicity mediated by alloantigen-specific CD4+ as well as Granule exocytosis, and not the Fas/Fas ligand system, is the main

  2013cites this paper
• A Missense Mutation in the Extracellular Domain of Fas: The Most Common Change in Argentinean Patients with Autoimmune Lymphoproliferative Syndrome Represents a Founder Effect

  2012cites this paper
• Immune Dysregulation Diseases

  2012cites this paper
• Disease causing mutations in the TNF and TNFR superfamilies: Focus on molecular mechanisms driving disease.

  2011cites this paper
• Autoimmune lymphoproliferative syndrome mimicking chronic active Epstein–Barr virus infection

  2011cites this paper
• Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.

  2011cites this paper
• Exonic deletion of CASP10 in a patient presenting with systemic juvenile idiopathic arthritis, but not with autoimmune lymphoproliferative syndrome type IIa

  2011cites this paper
• Scientific correspondence

  2011cites this paper
• Secondary anaplastic astrocytoma developing in a young adult with autoimmune lymphoproliferative syndrome (ALPS)

  2011cites this paper
• Underexpression and overexpression of Fas and Fas ligand: a double-edged sword.

  2010cites this paper
• Clues to immune tolerance: the monogenic autoimmune syndromes

  2010cites this paper
• L'inhibition de la voie Phosphoinositide-3 kinase (PI3K)/AKT induit un signal apoptotique via la redistribution du récepteur de mort CD95 dans les radeaux lipidiques

  2010cites this paper
• Residual CD95-Pathway Function in Children With Autoimmune Lymphoproliferative Syndrome Is Independent From Clinical State and Genotype of CD95 Mutation

  2009cites this paper
• Genetic defects of apoptosis and primary immunodeficiency.

  2008cites this paper
• Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome

  2007cites this paper
• Perforin-dependent apoptosis functionally compensates Fas deficiency in activation-induced cell death of human T lymphocytes.

  2007cites this paper
• Rituximab responsive immune thrombocytopenic purpura in an adult with underlying autoimmune lymphoproliferative syndrome due to a splice-site mutation (IVS7+2 T>C) affecting the Fas gene

  2007cites this paper
• The death domain superfamily in intracellular signaling of apoptosis and inflammation.

  2007cites this paper
• Autoimmune Lymphoproliferative Syndrome (ALPS): A Case with Congenital Onset

  2007cites this paper
• The Death Domain Superfamily in Intracellular Signaling of Apoptosis and Inflammation

  2007cites this paper
• Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype

  2006influential citation
• La modulation de l'apoptose dépendante du récepteur Fas : étude des évènements précoces de la voie de signalisation apoptotique dans un modèle de lymphocytes T humains

  2006cites this paper
• Autoimmune Lymphoproliferative Syndrome – Impaired Regulation of the Immune Response by Impaired Induction of Apoptosis

  2006cites this paper
• Autoimmune lymphoproliferative syndrome.

  2006cites this paper
• Inherited and acquired death receptor defects in human Autoimmune Lymphoproliferative Syndrome.

  2006cites this paper
• Autoimmune lymphoproliferative syndrome with somatic Fas mutations.

  2004cites this paper
• Primary Immunodeficiencies Inducing EBV-Associated Severe Illnesses.

  2004cites this paper
• Autoimmune lymphoproliferative syndrome: A cause of chronic splenomegaly, lymphadenopathy, and cytopenias in children—report on diagnosis and management of five patients

  2004cites this paper
• Autoimmune lymphoproliferative syndrome (ALPS).

  2003cites this paper
• [Lymphoproliferative disorders caused by hereditary genetic defects].

  2003cites this paper
• No association of two Fas gene polymorphisms with Hashimoto's thyroiditis and Graves' disease.

  2003cites this paper
• Autoimmune lymphoproliferative syndrome presenting with glomerulonephritis

  2003cites this paper
• Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways

  2003cites this paper
• Essential Roles of Perforin in Antigen-Specific Cytotoxicity Mediated by Human CD4+ T Lymphocytes: Analysis Using the Combination of Hereditary Perforin-Deficient Effector Cells and Fas-Deficient Target Cells 1

  2003cites this paper
• CD95 (APO‐1/FAS) deficiency in infant acute lymphoblastic leukemia: detection of novel soluble Fas splice variants

  2003cites this paper
• Cell-death signaling and human disease.

  2003cites this paper
• [Chronic active Epstein-Barr virus infection and related diseases].

  2003cites this paper
• Autoimmune Lymphoproliferative Syndrome

  2003cites this paper
• 乳児期早期に溶血性貧血と血小板減少で発症したAutoimmune Lymphoproliferative Syndromeの1例

  2003cites this paper
• N-Bak : a Neuron-Specific Splice Variant of Bak with anti-Apoptotic Properties

  2003cites this paper
• Autoimmune Lymphoproliferative Syndrome Presenting Hemolytic Anemia and Thrombocytopenia in Early Infancy

  2003cites this paper
• Autoimmune Lymphoproliferative Syndrome: An Inherited Disorder with a High Incidence of Autoimmune Cytopenias

  2003cites this paper
• Autoimmune lymphoproliferative syndrome

  2003cites this paper
• The conformational alteration of the mutated extracellular domain of Fas in an adult T cell leukemia cell line.

  2002cites this paper
• A composite picture of TcRα/β+ CD4-CD8- T cells (α/β-DNTCs) in humans with autoimmune lymphoproliferative syndrome

  2002cites this paper
• Overview of Epstein-Barr virus-associated diseases in Japan.

  2002cites this paper
• Significant role of Fas ligand‐binding but defective Fas receptor (CD95) in lymph node hyperplasia composed of abnormal double‐negative T cells

  2002cites this paper
• Hypo‐active variant of IL‐2 and associated decreased T cell activation contribute to impaired apoptosis in autoimmune prone MRL mice

  2002cites this paper
• Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency

  2002cites this paper
• A putative lipid transfer protein involved in systemic resistance signalling in Arabidopsis

  2002cites this paper
• A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome.

  2002cites this paper
• Autoimmune lymphoproliferative syndrome A genetic disorder of abnormal lymphocyte apoptosis

  2002cites this paper
• Autoimmune Lymphoproliferative Syndrome Type III: An Indefinite Disorder

  2001cites this paper
• Cell cycle phase-specific survival of CD95 ligand-challenged Jurkat cells: upregulation of heat-shock response.

  2001cites this paper
• Autoimmune lymphoproliferative syndrome: types I, II and beyond.

  2001cites this paper
• Brain Injury

  2001cites this paper
• Autoimmune Lymphoproliferative Syndrome vpe 111: An Indefinite Disorder

  2001cites this paper
• Autoimmune Lymphoproliferative Syndrome Type III, an Indefinite Disorder

  2001cites this paper
• Investigation of suspected deficient Fas-mediated apoptosis in a father and son.

  2001cites this paper
• Death Receptors in Acute Brain Injury

  2001cites this paper
• Fas and Fas ligand gene polymorphisms in primary Sjögren's syndrome.

  2000cites this paper
• Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders

  2000cites this paper
• Caspase-10 mutations in the autoimmune lymphoproliferative syndrome type II

  2000cites this paper
• Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival.

  2000cites this paper
• Pathophysiological roles of interleukin‐18 in inflammatory liver diseases

  2000cites this paper
• Hepatocyte Apoptosis Triggered by Natural Substances (Cytokines, Other Endogenous Molecules and Foreign Toxins)

  2000cites this paper
• Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans.

  2000cites this paper
• Autoimmune lymphoproliferative syndrome, a disorder of apoptosis.

  1999cites this paper
• Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.

  1999cites this paper
• Monocyte Rescue of Human T Cells from Apoptosis is CD40/CD154 Dependent

  1999cites this paper
• Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.

  1999cites this paper
• A Portrait of the Bcl-2 Protein Family: Life, Death, and the Whole Picture

  1999cites this paper
• Fas is expressed early in human thymocyte development but does not transmit an apoptotic signal.

  1999cites this paper
• Fas ligand-induced apoptosis.

  1999cites this paper